Taiwan Central Epidemic Command Center Gears up for Remdesivir-based COVID-19 Clinical Trials

Taiwan Central Epidemic Command Center Gears up for Remdesivir-based COVID-19 Clinical Trials

Taiwan’s Central Epidemic Command Center announced the commencement of clinical trials for the use of the antiviral drug remdesivir to treat the novel coronavirus (COVID-19). Moreover, the U.S. Food and Drug Administration (FDA) has approved the participation of...

Pin It on Pinterest